These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6593602)

  • 1. Metabolic basis of improved exercise tolerance: muscle phosphorylase deficiency after glucagon administration.
    Kono N; Mineo I; Sumi S; Shimizu T; Kang J; Nonaka K; Tarui S
    Neurology; 1984 Nov; 34(11):1471-6. PubMed ID: 6593602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study on glucagon effect between McArdle disease and Tarui disease.
    Mineo I; Kono N; Shimizu T; Sumi S; Nonaka K; Tarui S
    Muscle Nerve; 1984 Sep; 7(7):552-9. PubMed ID: 6242422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxanthine and Mcardle disease: a clue to metabolic stress in the working forearm.
    Brooke MH; Patterson VH; Kaiser KK
    Muscle Nerve; 1983; 6(3):204-6. PubMed ID: 6574314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII.
    Mineo I; Kono N; Shimizu T; Hara N; Yamada Y; Sumi S; Nonaka K; Tarui S
    J Clin Invest; 1985 Aug; 76(2):556-60. PubMed ID: 3861621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glycogenosis type V of adults: muscle phosphorylase deficiency].
    Coll Cantí J; Illa I; Beleta J; Anglada A; Pradas J; González Sastre F; Grau Veciana JM; Gella FJ
    Med Clin (Barc); 1986 Mar; 86(8):335-8. PubMed ID: 3458989
    [No Abstract]   [Full Text] [Related]  

  • 6. Ischemic exercise test: failure to detect partial expression of McArdle's disease.
    Taylor RG; Lieberman JS; Portwood MM
    Muscle Nerve; 1987; 10(6):546-51. PubMed ID: 3476851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 31-P NMR characterization of the metabolic anomalies associated with the lack of glycogen phosphorylase activity in human forearm muscle.
    Bendahan D; Confort-Gouny S; Kozak-Ribbens G; Cozzone PJ
    Biochem Biophys Res Commun; 1992 May; 185(1):16-21. PubMed ID: 1599452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset myophosphorylase deficiency (Mc Ardle's disease) with absence of myophosphorylase protein on SDS electrophoresis. The role of the ischemic forearm test.
    van Riet W; de Meirsman J; de Saedeleer J; Dom R; Carton H; van den Heede J; Bulcke JA
    Clin Neurol Neurosurg; 1985; 87(2):85-90. PubMed ID: 3861283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle glycogen phosphorylase deficiency.
    Moses SW
    Isr J Med Sci; 1989 Feb; 25(2):61-3. PubMed ID: 2703327
    [No Abstract]   [Full Text] [Related]  

  • 10. Absence of functional messenger RNA for glycogen phosphorylase in the muscle of two patients with McArdle's disease.
    Daegelen D; Munnich A; Levin MJ; Girault A; Goasguen J; Kahn A; Dreyfus JC
    Ann Hum Genet; 1983 May; 47(2):107-15. PubMed ID: 6576726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease?
    Preisler N; Orngreen MC; Echaniz-Laguna A; Laforet P; Lonsdorfer-Wolf E; Doutreleau S; Geny B; Akman HO; Dimauro S; Vissing J
    Neurology; 2012 Jan; 78(4):265-8. PubMed ID: 22238410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency?
    Ørngreen MC; Schelhaas HJ; Jeppesen TD; Akman HO; Wevers RA; Andersen ST; ter Laak HJ; van Diggelen OP; DiMauro S; Vissing J
    Neurology; 2008 May; 70(20):1876-82. PubMed ID: 18401027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myophosphorylase deficiency impairs muscle oxidative metabolism.
    Haller RG; Lewis SF; Cook JD; Blomqvist CG
    Ann Neurol; 1985 Feb; 17(2):196-9. PubMed ID: 3856415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glycogen storage disease associated with glycogen deposition in skeletal and heart muscles with low muscle phosphorylase activity].
    Uchida T; Kodama A; Takezawa M; Kijima M; Miyazaki Y; Yui T; Ono K; Ohwada K; Kariyone S
    Nihon Naika Gakkai Zasshi; 1985 Jul; 74(7):945-51. PubMed ID: 3863867
    [No Abstract]   [Full Text] [Related]  

  • 15. Depot-glucagon in the treatment of McArdle's disease.
    Day TJ; Mastaglia FL
    Aust N Z J Med; 1985 Dec; 15(6):748-50. PubMed ID: 3869441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of sympathetic activation during static exercise in patients with muscle phosphorylase deficiency (McArdle's disease).
    Pryor SL; Lewis SF; Haller RG; Bertocci LA; Victor RG
    J Clin Invest; 1990 May; 85(5):1444-9. PubMed ID: 2332499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired glycogen breakdown and synthesis in phosphoglucomutase 1 deficiency.
    Preisler N; Cohen J; Vissing CR; Madsen KL; Heinicke K; Sharp LJ; Phillips L; Romain N; Park SY; Newby M; Wyrick P; Mancias P; Galbo H; Vissing J; Haller RG
    Mol Genet Metab; 2017 Nov; 122(3):117-121. PubMed ID: 28882528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult muscle phosphorylase "b" kinase deficiency.
    Abarbanel JM; Bashan N; Potashnik R; Osimani A; Moses SW; Herishanu Y
    Neurology; 1986 Apr; 36(4):560-2. PubMed ID: 3083284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new variant of late-onset myophosphorylase deficiency.
    Kost GJ; Verity MA
    Muscle Nerve; 1980; 3(3):195-201. PubMed ID: 6929403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic control of cardiac output response to exercise in McArdle's disease.
    Lewis SF; Haller RG; Cook JD; Blomqvist CG
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Dec; 57(6):1749-53. PubMed ID: 6595253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.